Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
NCT06844422
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Ivonescimab
Sponsor
Shandong Cancer Hospital and Institute